No association of monocyte chemoattractant protein-1 22518 A/G polymorphism with the risk of primary glomerulonephritis in the Polish population

Molecular Biology Reports

Volumn 39, Issue 5, 2012, Pages 5933-5941

  Mostowska, Magdalena ^a   Lianeri, Margarita ^a   Oko, Andrzej ^a   Mostowska, Adrianna ^a   Jagodziński, Paweł P ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

C1GalT1; MCP 1 CCL2; Polymorphism; Primary glomerulonephritis

Indexed keywords

BETA 1,3 GLYCOSYLTRANSFERASE; GLYCOSYLTRANSFERASE; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG; CCL2 PROTEIN, HUMAN;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; FOCAL GLOMERULOSCLEROSIS; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GLOMERULONEPHRITIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MONOCYTE CHEMOTACTIC PROTEIN 1 GENE; POLISH; PREVALENCE; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN LOCALIZATION; PROTEIN POLYMORPHISM; ALLELE; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; POLAND; POPULATION GENETICS; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; CHEMOKINE CCL2; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GLOMERULONEPHRITIS; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLAND; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; YOUNG ADULT;

EID: 84863737267     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1405-y     Document Type: Article

References (48)

1. Mathieson PW (2007) Glomerulonephritis. Semin Immunopathol 29:315-316
2. Chadban SJ, Atkins RC (2005) Glomerulonephritis. Lancet 365:1797-1806
3. Mayadas TN, Rosetti F, Ernandez T, Sethi S (2010) Neutrophils: game changers in glomerulonephritis? Trends Mol Med 16:368-378
4. Timoshanko JR, Tipping PG (2005) Resident kidney cells and their involvement in glomerulonephritis. Curr Drug Targets Inflamm Allergy 4:353-362
5. Wada J, Sugiyama H, Makino H (2003) Pathogenesis of IgA nephropathy. Semin Nephrol 23:556-563
6. Gorgi Y, Sfar I, Goucha R, Aouadi H, Amri M, Makhlouf M, Ben Romdhane T, Cherif M, Jendoubi-Ayed S, Ben Abdallah T, Ayed K (2010) IL1/IL1 Ra, CTLA-4 and Apo1/Fas genes polymorphisms and susceptibility to IgA nephropathy in Tunisian patients. Tunis Med 88:789-793
7. Choi HJ, Cho JH, Kim JC, Seo HJ, Hyun SH, Kim GH, Choi JY, Choi HJ, Ryu HM, Cho JH, Park SH, Kim YL, Han S, Kim CD (2010) Interleukin-18, transforming growth factor-b, and vascular endothelial growth factor gene polymorphisms and susceptibility to primary glomerulonephritis. Tissue Antigens 76:289-296
8. Yu L, Jiang L, Zhou XJ, Zhu L, Zhang H (2010) Common genetic variants in the chromogranin a promoter are associated with renal injury in IgA nephropathy patients with malignant hypertension. Ren Fail 32:41-46
9. Brezzi B, Del Prete D, Lupo A, Magistroni R, Gomez-Lira M, Bernich P, Anglani F, Mezzabotta F, Turco A, Furci L, Ceol M, Antonucci F, Abaterusso C, Bonfante L, D'Angelo A, Albertazzi A, Gambaro G (2009) Primary IgA nephropathy is more severe in TGF-beta1 high secretor patients. J Nephrol 22:747-759
10. Pirulli D, Crovella S, Ulivi S, Zadro C, Bertok S, Rendine S, Scolari F, Foramitti M, Ravani P, Roccatello D, Savoldi S, Cerullo G, Lanzilotta SG, Bisceglia L, Zelante L, Floege J, Alexopoulos E, Kirmizis D, Ghiggeri GM, Frascà G, Schena FP, Amoroso A (2009) European IgAN Consortium. Genetic variant of C1GalT1 contributes to the susceptibility to IgA nephropathy. J Nephrol 22:152-159
11. Ohtsubo S, Iida A, Nitta K, Tanaka T, Yamada R, Ohnishi Y, Maeda S, Tsunoda T, Takei T, Obara W, Akiyama F, Ito K, Honda K, Uchida K, Tsuchiya K, Yumura W, Ujiie T, Nagane Y, Miyano S, Suzuki Y, Narita I, Gejyo F, Fujioka T, Nihei H, Nakamura Y (2005) Association of a single-nucleotide polymorphism in the immunoglobulin mu-binding protein 2 gene with immunoglobulin A nephropathy. J Hum Genet 50:30-35
12. Obara W, Iida A, Suzuki Y, Tanaka T, Akiyama F, Maeda S, Ohnishi Y, Yamada R, Tsunoda T, Takei T, Ito K, Honda K, Uchida K, Tsuchiya K, Yumura W, Ujiie T, Nagane Y, Nitta K, Miyano S, Narita I, Gejyo F, Nihei H, Fujioka T, Nakamura Y (2003) Association of single-nucleotide polymorphisms in the polymeric immunoglobulin receptor gene with immunoglobulin A nephropathy (IgAN) in Japanese patients. J Hum Genet 48:293-299
13. Li GS, Zhu L, Zhang H, Lv JC, Ding JX, Zhao MH, Shen Y, Wang HY (2007) Variants of the ST6GALNAC2 promoter influence transcriptional activity and contribute to genetic susceptibility to IgA nephropathy. Hum Mutat 28:950-957
14. Baggiolini M, Dewald B, Moser B (1994) Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 55:97-179
15. Viedt C, Orth SR (2002) Monocyte chemoattractant protein-1 (MCP-1) in the kidney: does it more than simply attract monocytes? Nephrol Dial Transplant 17:2043-2047
16. Panzer U, Thaiss F, Zahner G, Barth P, Reszka M, Reinking RR, Wolf G, Helmchen U, Stahl RA (2001) Monocyte chemoattractant protein-1 and osteopontin differentially regulate monocytes recruitment in experimental glomerulonephritis. Kidney Int 59:1762-1769
17. Stasikowska O, Wagrowska-Danilewicz M (2007) Chemokines and chemokine receptors in glomerulonephritis and renal allograft rejection. Med Sci Monit 13:RA31-RA36
18. Viedt C, Dechend R, Fei J, Hänsch GM, Kreuzer J, Orth SR (2002) MCP-1 induces inflammatory activation of human tubular epithelial cells: involvement of the transcription factors, nuclear factorkB and activating protein-1. J Am Soc Nephrol 13:1534-1547
19. Viedt C, Vogel J, Athanasiou T, Shen W, Orth SR, Kübler W, Kreuzer J (2002) Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kB and activator protein-1. Arterioscler Thromb Vasc Biol 22:914-920
20. Rovin BH, Lu L, Saxena R (1999) A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 259:344-348
21. Fenoglio C, Galimberti D, Lovati C, Guidi I, Gatti A, Fogliarino S, Tiriticco M, Mariani C, Forloni G, Pettenati C, Baron P, Conti G, Bresolin N, Scarpini E (2004) MCP-1 in Alzheimer's disease patients: A -2518G polymorphism and serum levels. Neurobiol Aging 25:1169-1173
22. Mori H, Kaneko Y, Narita I, Goto S, Saito N, Kondo D, Sato F, Ajiro J, Saga D, Ogawa A, Sakatsume M, Ueno M, Tabei K, Gejyo F (2005) Monocyte chemoattractant protein-1 A -2518G gene polymorphism and renal survival of Japanese patients with immunoglobulin A nephropathy. Clin Exp Nephrol 9:297-303
23. Steinmetz OM, Panzer U, Harendza S, Mertens PR, Ostendorf T, Floege J, Helmchen U, Stahl RA (2004) No association of the -2518 MCP-1 A/G promoter polymorphism with incidence and clinical course of IgA nephropathy. Nephrol Dial Transplant 19:596-601
24. Amore A, Cirina P, Conti G, Brusa P, Peruzzi L, Coppo R (2001) Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells. J Am Soc Nephrol 12:1862-1871
25. Urushihara M, Ohashi N, Miyata K, Satou R, Acres OW, Kobori H (2011) Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis. Hypertension 57:586-593
26. Wada T, Furuichi K, Sakai N, Iwata Y, Yoshimoto K, Shimizu M, Kobayashi K, Mukaida N, Matsushima K, Yokoyama H (2000) A new anti-inflammatory compound, FR167653, ameliorates crescentic glomerulonephritis in Wistar-Kyoto rats. J Am Soc Nephrol 11:1534-1541
27. Liu ZH, Chen SF, Zhou H, Chen HP, Li LS (2003) Glomerular expression of C-C chemokines in different types of human crescentic glomerulonephritis. Nephrol Dial Transplant 18: 1526-1534
28. Mezzano SA, Barría M, Droguett MA, Burgos ME, Ardiles LG, Flores C, Egido J (2001) Tubular NF-kappaB and AP-1 activation in human proteinuric renal disease. Kidney Int 60:1366-1377
29. Wada T, Yokoyama H, Furuichi K, Kobayashi KI, Harada K, Naruto M, Su SB, Akiyama M, Mukaida N, Matsushima K (1996) Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/ MCP-1). FASEB J 10:1418-1425
30. Le Hir M, Haas C, Marino M, Ryffel B (1998) Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice. Lab Invest 78:1625-1631
31. Chen YM, Lin SL, Chiang WC, Wu KD, Tsai TJ (2006) Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular diseases. Kidney Int 69:1410-1415
32. Sun Y, Yuan S, Xu X (2009) Expression of MCP-1 in renal tissues of patients with IgA nephropathy. Zhong Nan Da Xue Xue Bao Yi Xue Ban 34:1023-1028
33. Stangou M, Alexopoulos E, Papagianni A, Pantzaki A, Bantis C, Dovas S, Economidou D, Leontsini M, Memmos D (2009) Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy. Nephrology (Carlton) 14:613-620
34. Tucci M, Barnes EV, Sobel ES, Croker BP, Segal MS, Reeves WH, Richards HB (2004) Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis. Arthritis Rheum 50: 1842-1849
35. Brown KS, Nackos E, Morthala S, Jensen LE, Whitehead AS, Feldt Von (2007) Monocyte chemoattractant protein-1: plasma concentrations and A(-2518)G promoter polymorphism of its gene in systemic lupus erythematosus. J Rheumatol 34: 740-746
36. Hou S, Yang P, Du L, Jiang Z, Mao L, Shu Q, Zhou H, Kijlstra A (2010) Monocyte chemoattractant protein-1 -2518A/G single nucleotide polymorphism in Chinese Han patients with ocular Behçet's disease. Hum Immunol 71:79-82
37. Ozyürek AR, Gürses D, Ulger Z, Levent E, Bakiler AR, Berdeli A (2007) Allelic frequency of the MCP-1 promoter -2518 polymorphism in the Turkish population and in Turkish patients with juvenile rheumatoid arthritis. Clin Rheumatol 26:546-550
38. Karrer S, Bosserhoff AK, Weiderer P, Distler O, Landthaler M, Szeimies RM, Müller-Ladner U, Schölmerich J, Hellerbrand C (2005) The -2518 promotor polymorphism in the MCP-1 gene is associated with systemic sclerosis. J Invest Dermatol 124:92-98
39. Wang L, Yang L, Gao L, Gao TW, Li W, Liu YF (2008) A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with psoriasis. Int J Immunogenet 35(1):45-49
40. Ogimoto A, Okayama H, Nagai T, Ohtsuka T, Suzuki J, Inoue K, Nishimura K, Shigematsu Y, Tabara Y, Kohara K, Miki T, Higaki J (2009) Association of monocyte chemoattractant protein 1 gene polymorphism with susceptibility to nonfamilial idiopathic dilated cardiomyopathy. J Cardiol 54:66-70
41. Jemaa R, Rojbani H, Kallel A, Ben Ali S, Feki M, Chabrak S, Elasmi M, Taieb SH, Sanhaji H, Souheil O, Mechmeche R, Kaabachi N (2008) Association between the -2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and myocardial infarction in Tunisian patients. Clin Chim Acta 390:122-125
42. Bucova M, Lietava J, Mrazek F, Petrkova J, Penz P, Bernadic M, Buckingham TA, Petrek M (2009) The MCP-1-2518 (A/G) single nucleotide polymorphism is associated with ischemic heart disease and myocardial infarction in men in the Slovak population. Bratisl Lek Listy 110:385-389
43. Yuasa S, Maruyama T, Yamamoto Y, Hirose H, Kawai T, Matsunaga-Irie S, Itoh H (2009) MCP-1 gene A-2518G polymorphism and carotid artery atherosclerosis in patients with type 2 diabetes. Diabetes Res Clin Pract 86:193-198
44. Jemaa R, Ben Ali S, Kallel A, Omar S, Feki M, Elasmi M, Haj-Taïeb S, Sanhaji H, Kaabachi N (2009) Association between the -2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and hypertension in Tunisian patients. Clin Biochem 42:34-37
45. Piotrowski P, Lianeri M, Gasik R, Roszak A, Olesińska M, Jagodziński PP (2010) Monocyte chemoattractant protein-1 - 2518A/G single nucleotide polymorphism might be associated with renal disease and thrombocytopenia of SLE. J Biomed Biotechnol 2010:130265
46. Malafronte P, Vieira JM Jr, Pereira AC, Krieger JE, Barros RT, Woronik V (2010) Association of the MCP-1 -2518A/G polymorphism and no association of its receptor CCR2-64 V/I polymorphism with lupus nephritis. J Rheumatol 37:776-782
47. Sica A, Wang JM, Colotta F, Dejana E, Mantovani A, Oppenheim JJ, Larsen CG, Zachariae CO, Matsushima K (1990) Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J Immunol 144:3034-3038
48. Satriano JA, Hora K, Shan Z, Stanley ER, Mori T, Schlondorff D (1993) Regulation of monocyte chemoattractant protein-1 and macrophage colony stimulating factor-1 by IFN-gamma, tumor necrosis factor-alpha, IgG aggregates, and cAMP in mouse mesangial cells. J Immunol 150:1971-1978